Terns Pharmaceuticals, Inc. (TERN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.76B |
| Enterprise Value | 3.24B |
| P/E Ratio | -51.41 |
| PEG Ratio | -5.51 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.9 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -40.01 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.09 |
| Return On Equity | -0.2 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -95.13M |
| Net Income | -96.21M |
| Diluted EPS | -1.03 |
| Total Cash | 1.02B |
| Total Cash/Share | 10.94 |
| Total Debt | 919,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 62.41 |
| Book Value Per Share | 10.8 |
| 52-Week Change | 1,220.45 |
| 52-Week High | 53.19 |
| 52-Week Low | 2.66 |
| Moving Average 50 Days | 50.15 |
| Moving Average 200 Days | 29.48 |
| Average Volume | 5.92M |
| Shares Outstanding | 90.08M |
| % Held by Institutions | 133.92 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |